In the recent weeks, the Turkish Pharmaceuticals and Medical Devices Authority published the (1) Guideline to Good Pharmacovigilance Module 10 — Premarketing Benefit/Risk Assessment, (2) Guideline to Good Pharmacovigilance Module 11 — Post-marketing Benefit/Risk Assessment and (3) Draft Guideline on the Use of Health Claims